pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06698003: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: T-Cell Leukemia/Lymphoma, Adult, T-cell Leukemia/Lymphoma, T-cell Leukemia, Lymphoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07050927: Long-Term Effect of Online Occupational Therapy-Based Parent Training on Feeding Problems in Infants

Sponsor: Ankara Medipol University. Phase: NA. Conditions: Feeding Difficulties, Feeding Problems, Food Neophobia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07542561: AI-Assisted Mindfulness Intervention in Emotional Distress

Sponsor: Xinghua Liu. Phase: NA. Conditions: Subclinical Depression, Subclinical Anxious Adults, Subclinical Emotional Distress

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06512961: Applicability of Tissue Flossing for Blood Flow Restriction in the Upper Limb: Reliability and Performance Analysis

Sponsor: Paulista University. Phase: NA. Conditions: Hypertrophy, Muscle Strength

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06480461: A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd.. Phase: PHASE1. Conditions: Parkinson's Disease

full page →ctgov ↗
›WITHHELDphase readoutNCT06709261: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT07333742: A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

Sponsor: LG Chem. Phase: PHASE1. Conditions: Fed Conditions, Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07258303: Oral-Spray Bacillus Spore Probiotics for Periodontal Disease Prevention and Supprotive Treatment in the Elderly

Sponsor: Anabio R&D. Phase: NA. Conditions: Periodontal Disease, Oral Deseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07555561: Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

Sponsor: Beijing Boren Hospital. Phase: PHASE1. Conditions: Relapsed/Refractory Central Nervous System Lymphoma, Relapsed/Refractory Primary Central Nervous System Lymphoma, Relapsed/Refractory Secondary Central Nervous System Lymphoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07476742: Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotions in Patients Undergoing Cardiac Surgery

Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Postoperative Delirium (POD), Postoperative, Anxiety, Depression, Cardiac Surgical Procedures

full page →ctgov ↗
›COMPLETEDphase readoutNCT07479342: The Effect of Modern Teaching Method: Gamification in Orthodontics

Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Gamification in Health Education

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07558642: Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients

Sponsor: Antalya Training and Research Hospital. Phase: NA. Conditions: Stellate Ganglion Block

full page →ctgov ↗
›COMPLETEDphase readoutNCT05610527: Hormonal Influences on Inflammatory Bowel Diseases

Sponsor: University of Utah. Phase: . Conditions: Inflammatory Bowel Diseases, Contraception, Menstrual Problem

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07027527: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

Sponsor: Apogee Therapeutics, Inc.. Phase: PHASE1. Conditions: Atopic Dermatitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07526688: Aerobic Physical Activity and Orofacial Myofascial Pain

Sponsor: University Hospital, Brest. Phase: NA. Conditions: Temporomandibular Disorders (TMD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07181161: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Metastatic Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07404761: Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments

Sponsor: Motion Informatics LTD. Phase: NA. Conditions: Stroke, Upper-limb Motor Impairment, Hemiparesis, Spinal Cord Injury, Traumatic Brain Injury

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04214561: Relationship Between Selected Parameters and Bruxism

Sponsor: Wroclaw Medical University. Phase: . Conditions: Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain, Anxiety, Mental Status Change, Temporomandibular Disorder

full page →ctgov ↗
›TERMINATEDphase readoutNCT05468203: PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care

Sponsor: The George Institute. Phase: PHASE3. Conditions: Acute Kidney Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07437703: Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, an RCT

Sponsor: Fraser Health. Phase: NA. Conditions: Labour Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06152627: Voice Therapy Per the Rehabilitation Treatment Specification System

Sponsor: Massachusetts General Hospital. Phase: . Conditions: Muscle Tension Dysphonia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04953442: Fit 24 Technology Intervention YOUTH

Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05202288: Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE2. Conditions: Ebola Virus Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07557888: A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate (OM-85) Combined With Antihistamines in the Treatment of Chronic Spontaneous Urticaria (CSU): A Single-Centre, Observational, Cohort Study

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Phase: . Conditions: Chronic Spontaneous Urticaria (CSU)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07052903: TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Sponsor: Alnylam Pharmaceuticals. Phase: PHASE3. Conditions: Transthyretin Amyloidosis With Cardiomyopathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT04027868: Genomic BRCA and Extensive ovArian Cancer Testing

Sponsor: ARCAGY/ GINECO GROUP. Phase: . Conditions: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05855668: Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Alcohol Use Disorder, Cannabis Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT03883217: Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT03048240: INtraoperative photoDYnamic Therapy of GliOblastoma

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Glioblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06479174: Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke

Sponsor: University of New Mexico. Phase: NA. Conditions: Stroke, Ischemic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07242118: Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Breast Cancer Female

full page →ctgov ↗
›RECRUITINGphase readoutNCT05565118: Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

Sponsor: Case Comprehensive Cancer Center. Phase: PHASE1. Conditions: High Grade Glioma, Glioblastoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02489318: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Prostate Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07266090: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

Sponsor: Viatris Pharmaceuticals Co., Ltd.. Phase: PHASE2. Conditions: SLE - Systemic Lupus Erythematosus

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03875690: Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: PHASE3. Conditions: Elective Surgery for Any Digestive Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT04879290: Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit

Sponsor: University Hospital, Caen. Phase: NA. Conditions: Anesthesia, Atelectasis, Postoperative Complications, Hypoxemia, Hyperoxia

full page →ctgov ↗
›RECRUITINGphase readoutNCT05085210: Improving Visual Field Deficits With Noninvasive Brain Stimulation

Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Visual Field Defect, Peripheral, Stroke, Visual Impairment, Hemianopsia, Quadrantanopia, Cortical Blindness, Visual Field Defect Homonymous Bilateral, Occipital Lobe Infarct, Visual Fields Hemianopsia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06251310: SW-682 in Advanced Solid Tumors

Sponsor: SpringWorks Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumor, Mesothelioma, Malignant

full page →ctgov ↗
›RECRUITINGphase readoutNCT06633913: Concurrent TMS-fMRI

Sponsor: Jing Jiang. Phase: NA. Conditions: Healthy Control, Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT06368323: Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia

Sponsor: University of Ottawa. Phase: NA. Conditions: Aphasia

full page →ctgov ↗
›COMPLETEDphase readoutNCT03391323: Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study

Sponsor: David F. Scott, MD. Phase: NA. Conditions: Osteoarthritis, Osteoarthritis, Knee, Joint Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT06795659: Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

Sponsor: The University of Texas Health Science Center at San Antonio. Phase: PHASE1. Conditions: Post Traumatic Stress Disorder PTSD

full page →ctgov ↗
›RECRUITINGphase readoutNCT05051059: Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Soft Tissue Sarcoma, Bone Sarcoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02400359: Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Obesity, Weight Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT05758480: Characterization of the Immunometabolic Signature in Long COVID-19.

Sponsor: University Hospital, Angers. Phase: NA. Conditions: Long COVID

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07402096: Effect of a Mindfulness-Based Stress Reduction Program on Hot Flashes and Sleep Quality in Menopausal Women: A Randomized Controlled Trial

Sponsor: Inonu University. Phase: NA. Conditions: Menopause, Hot Flashes, Sleep Wake Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT07156162: Effectiveness of Taste vs. Health-Based Messaging to Improve Diet Quality

Sponsor: Penn State University. Phase: NA. Conditions: Behavior, Health

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07539662: Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: NA. Conditions: ALS (Amyotrophic Lateral Sclerosis)

full page →ctgov ↗
›TERMINATEDphase readoutNCT02886546: Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy

Sponsor: Hallym University Kangnam Sacred Heart Hospital. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07444346: Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: . Conditions: Coronary Artery Calcification, Coronary Artery Disease

full page →ctgov ↗
← prev
page 67 of 161
next →